Natural Anticancer Agents: Their Therapeutic Potential, Challenges,s and Promising Outcomes

Area of Science:

• Phytochemistry
• Pharmacology
• Oncology

Background:

• Cancer is a leading global cause of death, with current treatments like chemotherapy and radiation therapy having significant toxic effects.
• Plant-derived compounds have demonstrated considerable potential as anticancer agents, exhibiting antitumor activity across various cancer cell lines.
• Several naturally occurring drugs (e.g., vincristine, paclitaxel) are already in clinical use, fueling interest in novel phytoconstituents.

Purpose of the Study:

• To review various plants and their key phytoconstituents for anticancer activity.
• To analyze the source, anticancer properties, and toxicity profiles of selected plant-based compounds.
• To identify potential clinical candidates among phytoconstituents with superior efficacy.

Main Methods:

• Literature review of plants with reported anticancer activities.
• Identification of key phytoconstituents within selected plants.
• Evaluation of anticancer activity and toxicity data for these compounds.

Main Results:

• Several plants, including Boswellia serrata, Panax ginseng, and Nigella sativa, were analyzed for their anticancer potential.
• Specific phytoconstituents such as boswellic acid, sulforaphane, and ginsenoside demonstrated significant anticancer activity.
• These compounds showed comparable or superior efficacy to standard anticancer drugs in preclinical evaluations.

Conclusions:

• Plant-derived compounds represent a promising source for novel anticancer therapeutics.
• Phytoconstituents like boswellic acid, sulforaphane, and ginsenoside exhibit potent anticancer effects and warrant further clinical investigation.
• Natural products offer a valuable avenue for developing safer and more effective cancer treatments.